BSE · PHARMAID
Pharmaids Pharmaceuticals Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,877
of 5,004 stocks
🏆 New peak
▲ 391W
Peak #2,877 · 01 Oct 2026
A microcap name in Healthcare, Pharmaids Pharmaceuticals Ltd. trades at an undemanding earnings multiple, is growing revenue rapidly, and has a subdued return on equity.
Market Cap
103.69 Cr
P/E Ratio
8.88
P/B Ratio
2.18
ROE
-24.31%
ROCE
-24.15%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 4.12 Cr | 7.18 Cr | 5.43 Cr | 8.60 Cr |
| Net Profit | 1.87 Cr | -1.08 Cr | -2.65 Cr | -2.53 Cr |
| EPS | 0.63 | 0.51 | 0.70 | 0.70 |
| Operating Profit | -1.18 Cr | -71.71 L | -2.90 Cr | -5.57 Cr |
Shareholding pattern
Promoter
32.99%
Public
67.01%
PUBLIC BREAKDOWN
Individuals
48.55%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.